Prevalence and Distribution Profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis Responsible for Superficial Candidiasis in a Chinese University Hospital

Mycopathologia

Volumn 173, Issue 4, 2012, Pages 229-234

  Feng, Xiaobo ^a   Ling, Bo ^a   Yang, Guimei ^b   Yu, Xia ^a   Ren, Daming ^b   Yao, Zhirong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Candida parapsilosis; Molecular typing; Superficial candidiasis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CANDIDIASIS; CHILD; CHINA; CLASSIFICATION; CROSS INFECTION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; STATISTICS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CHINA; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

CANDIDA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS;

EID: 84857903828     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9496-5     Document Type: Article

References (25)

1. Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008; 21: 606-25.
2. van Asbeck EC, Clemons KV, Stevens DA. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Crit Rev Microbiol. 2009; 35: 283-309.
3. López-Martínez R. Candidosis, a new challenge. Clin Dermatol. 2010; 28: 178-84.
4. Simonnet C, Berger F, Gantier JC. Epidemiology of superficial fungal diseases in French Guiana: a three-year retrospective analysis. Med Mycol. 2011; doi: 10. 3109/13693786. 2011. 558929.
5. Figueiredo VT, de Assis Santos D, Resende MA, Hamdan JS. Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections. Mycopathologia. 2007; 164: 27-33.
6. Jayatilake JA, Tilakaratne WM, Panagoda GJ. Candidal onychomycosis: a mini-review. Mycopathologia. 2009; 168: 165-73.
7. Godoy-Martinez P, Nunes FG, Tomimori-Yamashita J, Urrutia M, Zaror L, Silva V, Fischman O. Onychomycosis in São Paulo, Brazil. Mycopathologia. 2009; 168: 111-6.
8. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005; 43: 284-92.
9. Orsi CF, Colombari B, Blasi E. Candida metapsilosis as the least virulent member of the 'C. parapsilosis' complex. Med Mycol. 2010; 48: 1024-33.
10. Gácser A, Schäfer W, Nosanchuk JS, Salomon S, Nosanchuk JD. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol. 2007; 44: 1336-41.
11. Lattif AA, Mukherjee PK, Chandra J, Swindell K, Lockhart SR, Diekema DJ, Pfaller MA, Ghannoum MA. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int J Med Microbiol. 2010; 300: 265-70.
12. van Asbeck E, Clemons KV, Martinez M, Tong AJ, Stevens DA. Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagn Microbiol Infect Dis. 2008; 62: 106-9.
13. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol. 2008; 46: 2659-64.
14. Gomez-Lopez A, Alastruey-Izquierdo A, Rodriguez D, Almirante B, Pahissa A, Rodriguez-Tudela JL, Cuenca-Estrella M. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother. 2008; 52: 1506-9.
15. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J Clin Microbiol. 2009; 47: 2392-7.
16. Gonçalves SS, Amorim CS, Nucci M, Padovan AC, Briones MR, Melo AS, Colombo AL. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin Microbiol Infect. 2010; 16: 885-7.
17. Cantón E, Espinel-Ingroff A, Pemán J, del Castillo L. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrob Agents Chemother. 2010; 54: 2194-7.
18. de Toro M, Torres MJ, Maite R, Aznar J. Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect. 2011; 17: 418-24.
19. Tay ST, Na SL, Chong J. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J Med Microbiol. 2009; 58: 185-91.
20. Szabó Z, Szilágyi J, Tavanti A, Kardos G, Rozgonyi F, Bayegan S, Majoros L. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology. Diagn Microbiol Infect Dis. 2009; 64: 283-8.
21. Tavanti A, Hensgens LA, Ghelardi E, Campa M, Senesi S. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol. 2007; 45: 1455-62.
22. James WD, Berger TG, Elston DM. Diseases resulting from fungi and yeasts. In: Saunders WB, editor. Andrews' diseases of the skin: clinical dermatology. 10th ed. Philadelphia, PA: Saunders Elsevier; 2006. pp. 297-332.
23. Murray CK, Beckius ML, Green JA, Hospenthal DR. Use of chromogenic medium in the isolation of yeasts from clinical specimens. J Med Microbiol. 2005; 54: 981-5.
24. Pincus DH, Orenga S, Chatellier S. Yeast identification-past, present, and future methods. Med Mycol. 2007; 45: 97-121.
25. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Identification and susceptibility profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. J Clin Microbiol. 2009; 47: 242-4.